Ca(2+)-activated K(+) channels as therapeutic targets for myocardial and vascular protection.
Small- and large-conductance Ca(2+)-activated K(+)channels (SKCa and BKCa, respectively) may be important targets for therapeutic interventions in a variety of cardiac conditions. In cardiomyocytes, BKCa channels are localized to mitochondria where they beneficially modulate reactive oxygen species, mitochondrial Ca(2+), and respiration. In vascular smooth muscle cells, BKCa channels regulate vascular tone and promote vasodilation. Activation of BKCa channels has demonstrated significant cardioprotection following ischemic injury, including improved function and reduced infarct size. SKCa channels are expressed in both the membrane and mitochondria of cardiomyocytes. Modulation of cardiomyocyte SKCa channels may be beneficial for arrhythmia, heart failure, and ischemia. Mitochondrial SKCa channels may provide similar benefit to BKCa channels. In addition, activation of SKCa channels on the endothelium promotes vasodilation. This mini-review focuses on the modulation of cardiomyocyte BKCa and SKCa channels for cardioprotection and briefly address associated potential therapeutic benefits in the coronary circulation.
Department of Surgery, Cardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University.
Richard T
RT
Clements
Dmitry
D
Terentyev
Frank W
FW
Sellke
D000818:Animals; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000473:pathology; D006331:Heart Diseases / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D006801:Humans; D008929:Mitochondria, Heart / Q000378:metabolism / Q000473:pathology; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D024681:Potassium Channels, Calcium-Activated / Q000378:metabolism*; D014652:Vascular Diseases / Q000378:metabolism / Q000473:pathology / Q000628:therapy
D024681:Potassium Channels, Calcium-Activated